Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Daily Archives: July 13, 2022

  1. Home>
  2. 2022>
  3. July>
  4. 13
Preliminary Data Available on Vurolenatide for Short Bowel Syndrome
source: pixabay.com

Preliminary Data Available on Vurolenatide for Short Bowel Syndrome

  • Post author:Jessica Lynn
  • Post published:July 13, 2022
  • Post category:Short bowel syndrome

  Medical research and clinical trials are extremely important tools in learning more about specific diseases, as well as understanding and evaluating potential treatments. For example, the Phase 2 VIBRANT…

Continue Reading Preliminary Data Available on Vurolenatide for Short Bowel Syndrome
These Phase 2 Mesothelioma Trial Results Looks Promising
source: pixabay.com

These Phase 2 Mesothelioma Trial Results Looks Promising

  • Post author:James Moore
  • Post published:July 13, 2022
  • Post category:Malignant pleural mesothelioma/Mesothelioma

According to a story from Healio, a recent phase 2 clinical trial found that treatment with vinorelbine plus active supportive care offered greater progression-free survival than active supportive care on…

Continue Reading These Phase 2 Mesothelioma Trial Results Looks Promising
Paxalisib Earns Orphan Drug Designation for Atypical Teratoid Rhabdoid Tumors
source: pixabay.com

Paxalisib Earns Orphan Drug Designation for Atypical Teratoid Rhabdoid Tumors

  • Post author:Jessica Lynn
  • Post published:July 13, 2022
  • Post category:Atypical Teratoid Rhabdoid Tumor

Those living with rare diseases or conditions often face difficulty in finding treatment options - or even spurring researchers to make headway within their disease states. To combat this and…

Continue Reading Paxalisib Earns Orphan Drug Designation for Atypical Teratoid Rhabdoid Tumors
A Growing List of Options for Psoriatic Arthritis Patients

A Growing List of Options for Psoriatic Arthritis Patients

  • Post author:Rose Duesterwald
  • Post published:July 13, 2022
  • Post category:Psoriatic Arthritis

A recent article at Healio Rheumatology highlights a presentation given by Dr. Arthur Kavanaugh of the University of California to attendees at the 2022 Clinical Rheumatology Congress East. Dr. Kavanaugh…

Continue Reading A Growing List of Options for Psoriatic Arthritis Patients
July 23rd Is World Castleman Disease Day

July 23rd Is World Castleman Disease Day

  • Post author:Alyssa Stevens
  • Post published:July 13, 2022
  • Post category:Castleman Disease

Did you know that July 23 is World Castleman Disease Day? Each year, this day is dedicated to bringing awareness to those who are affected by Castleman disease, including patients, family…

Continue Reading July 23rd Is World Castleman Disease Day
Patient Story: Writing to Process a Porphyria Diagnosis
Free-Photos / Pixabay

Patient Story: Writing to Process a Porphyria Diagnosis

  • Post author:Alyssa Stevens
  • Post published:July 13, 2022
  • Post category:porphyria

In a recent article at Porphyria News, Claire Richmond shares how writing has helped her process her diagnosis of porphyria and to feel connected to the porphyria community. Claire Richmond’s…

Continue Reading Patient Story: Writing to Process a Porphyria Diagnosis

Featured


Picture of Family


Metastatic Breast Cancer: Navigating Grief


Picture of Ralph Family walking


Rethinking What It Means to Live With Acromegaly


Illustration of mentor program members


The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info